Organogenesis Holdings Inc. (NASDAQ: ORGO), a notable player in the regenerative medicine landscape, is capturing investor attention with a striking potential upside of 112.50%. As the company navigates the complex..
COMPASS Pathways Plc (NASDAQ: CMPS) is currently capturing the attention of investors with its promising advancements in mental health treatments and an intriguing potential upside of 135.88%. As a biotechnology..
Verastem, Inc. (NASDAQ: VSTM), a U.S.-based biopharmaceutical company, is making waves in the biotechnology sector with its innovative approach to cancer treatment. As a development-stage company, Verastem focuses on creating..
Gyre Therapeutics, Inc. (NASDAQ: GYRE), a pioneering biopharmaceutical company, is making waves in the healthcare sector with its innovative approach to tackling organ fibrosis through small-molecule drugs. Situated in the..
MBX Biosciences, Inc. (MBX), a clinical-stage biopharmaceutical company specializing in precision peptide therapies, is garnering significant attention from investors due to its promising pipeline and potential market advancements. With a..
Neuropace, Inc. (NASDAQ: NPCE), a pioneering company in the medical device sector, is capturing investor attention with its innovative solutions in the treatment of drug-resistant focal epilepsy. Founded in 1997..
Kura Oncology, Inc. (NASDAQ: KURA), a prominent player in the biotech sector, continues to capture investor attention with its promising pipeline of cancer therapies. Headquartered in San Diego, this clinical-stage..
AbCellera Biologics Inc. (NASDAQ: ABCL), a Canadian biotechnology firm, presents an exciting opportunity for investors in the healthcare sector with a remarkable potential upside of 111.93%. Specializing in the discovery..
EyePoint, Inc. (NASDAQ: EYPT), a dynamic player in the biotechnology sector, has captured investor attention with a promising 120.9% potential upside, according to analyst ratings. Specializing in therapeutics for serious..
Inventiva S.A. (IVA), a French biotechnology company listed on the American Depositary Receipt (ADR) market, is capturing investor attention with its promising pipeline and compelling analyst endorsements. With a current..
Investors eyeing opportunities in the healthcare sector might find SIGA Technologies Inc. (NASDAQ: SIGA) an intriguing prospect. With a market capitalization of $481.94 million, this New York-based pharmaceutical company is..
Investors examining Cross Country Healthcare, Inc. (NASDAQ: CCRN) are evaluating a company deeply rooted in the healthcare sector, specifically within the medical care facilities industry. Based in Boca Raton, Florida,..
Investors looking to tap into the burgeoning field of biotechnology may find Replimune Group, Inc. (REPL) an intriguing prospect. This clinical-stage company, with a market cap of $619.7 million, is..
Talkspace, Inc. (NASDAQ: TALK), a pioneering force in the virtual behavioral healthcare sector, is capturing the attention of investors thanks to its impressive potential upside and a strong lineup of..
Simulations Plus, Inc. (NASDAQ: SLP), a notable player in the Healthcare sector specializing in Health Information Services, presents a compelling case for investors seeking exposure to innovative solutions in drug..
Fortrea Holdings Inc. (NASDAQ: FTRE), a burgeoning player in the healthcare sector, is making waves in the biotechnology industry. With a market cap of $1.6 billion, this U.S.-based contract research..
Ginkgo Bioworks Holdings, Inc. (NASDAQ: DNA), a promising player in the biotechnology sector, is making waves with its innovative approach to cell programming and biosecurity. Despite the turbulent market conditions,..
MeiraGTx Holdings plc (NASDAQ: MGTX), a clinical-stage gene therapy company, stands at an intriguing intersection of innovation and investment opportunity. With a market capitalization of $668.88 million, the company is..
Zenas BioPharma, Inc. (NASDAQ: ZBIO) is capturing the attention of investors with its significant upside potential, underscored by a 99.75% potential gain based on current analyst target prices. As a..
STAAR Surgical Company (NASDAQ: STAA), a key player in the healthcare sector, specifically in the medical instruments and supplies industry, has been a subject of significant interest among investors. The..
